Abstract
Objective
To describe the impact of co-morbidities, visual acuity, diabetic retinopathy (DR) grade, and macular edema (ME) on the health-related quality of life (HRQOL) among patients with diabetic retinopathy.
Methods
Analysis of data of 207 patients with diabetic retinopathy from Germany in 2003. HRQOL assessment was done using the generic (SF-12) questionnaire. It was hypothesized that exogenous variables (co-morbidities, visual acuity impairment, DR, and ME) would have an impact on HRQOL. Using a structural equation modelling procedure, the effects of exogenous variables on endogenous variables physical component summaries (PSC) and mental component summaries (MCS) reflecting HRQOL were tested.
Results
The number of co-morbidities had a negative effect on visual acuity (b = −0.26, standardized) and a similar negative effect on PCS (b = −0.27). DR grade had a negative effect on visual acuity (b = −0.19) and a positive effect on the variable ME (b = 0.44). ME displayed a negative effect on visual acuity (b = −0.58) and also on MCS (b = −0.29). Visual acuity had a positive effect (b = 0.48) on PCS.
Conclusions
Presence of DR and ME, visual acuity impairment and patient co-morbidities lead to significant impairment of both the physical and mental components of HRQOL.
Similar content being viewed by others
Abbreviations
- DM:
-
Diabetes mellitus
- DR:
-
Diabetic retinopathy
- NPDR:
-
Non-proliferative diabetic retinopathy
- PDR:
-
Proliferative diabetic retinopathy
- ME:
-
Macular edema
- NCSME:
-
No clinically significant macular edema
- CSME:
-
Clinically significant macular edema
- SEM:
-
Structural equation modelling
- HRQOL:
-
Health-related quality of life
- RetDQoL:
-
Retinopathy Dependent Quality of Life questionnaire
- RetTSQ:
-
Retinopathy Treatment Satisfaction Questionnaire
- SF-12:
-
Short-Form Health Survey
- PSC:
-
Physical Component Summaries
- MCS:
-
Mental Component Summaries
- FIML:
-
Full Information Maximum Likelihood
- SD:
-
Standard deviation
- IQR:
-
Interquartile range
References
Horle S, Gruner F, Kroll P (2002) Epidemiology of diabetes-induced blindness: a review. Klin Monatsbl Augenheilkd 219:777–784 doi:10.1055/s-2002-36318
Knudsen S, Bek T, Poulsen P, Hove M, Rehling M, Mogensen C (2002) Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 25:2328–2334 doi:10.2337/diacare.25.12.2328
Funatsu H, Yamashita H, Ikeda T, Nakanishi Y, Kitano S, Hori S (2002) Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 133:537–543 doi:10.1016/S0002-9394(02)01323-5
Javitt J, Aiello L (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124:164–169
World Health Organisation (2002) Diabetes mellitus. Fact sheet No 138. Retrieved January 12, 2006, from http://www.who.int/mediacentre/factsheets/fs138/en/print.html
Lamoureux E, Hassell J, Keeffe J (2004) The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol 122:84–88 doi:10.1001/archopht.122.1.84
Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924 doi:10.1001/archinte.164.17.1917
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682 doi:10.1016/S0161-6420(03)00475-5
Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J (2008) The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol 246:151–159 doi:10.1007/s00417-007-0573-x
Ware J, Kosinski M, Keller S (1996) A 12-Item Short-Form Health Survey. Med Care 34:220–233 doi:10.1097/00005650-199603000-00003
Ware J, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30:473–483 doi:10.1097/00005650-199206000-00002
Woodcock A, Bradley C, Plowright R, Ffytche T, Kennedy-Martin T, Hirsch A (2004) The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Couns 53:365–383 doi:10.1016/j.pec.2003.10.007
Woodcock A, Bradley C, Plowright R, Kennedy-Martin T, Hirsch A, Ffytche T (2005) Development of the new retinopathy treatment satisfaction questionnaire (ReTSQ). Int Congr Ser 1282:342–346 doi:10.1016/j.ics.2005.04.011
Bollen K (1989) Structural equations with latent variables. Wiley, New York
Byrne B (2001) Structural equation modeling with AMOS. Lawrence Erlbaum Associates, Rahwah, NJ
Muthén L, Muthén B (2007) Mplus user’s guide. Muthén & Muthén, Los Angeles, CA
Flora D, Curran P (2004) An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods 9:466–491 doi:10.1037/1082-989X.9.4.466
Schafer J, Graham J (2002) Missing data: our view of the state of the art. Psychol Methods 7:147–177 doi:10.1037/1082-989X.7.2.147
Hu L, Bentler P (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6:1–55
Marsh H, Hau K, Wen Z (2004) In search of golden rules: comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler’s (1999) findings. Struct Equ Modeling 11:320–341 doi:10.1207/s15328007sem1103_2
Hahl J, Hamalainen H, Sintonen H, Simell T, Arinen S, Simell O (2002) Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res 11:427–436 doi:10.1023/A:1015684100227
Maddigan S, Feeny D, Johnson J (2005) Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res 14:1311–1320 doi:10.1007/s11136-004-6640-4
Lloyd C, Matthews K, Wing R, Orchard T (1992) Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 15:166–172 doi:10.2337/diacare.15.2.166
Muñoz B, West S, Rubin G, Schein O, Quigley H, Bressler S, Bandeen-Roche K (2000) Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 118:819–825
Tielsch J, Javitt J, Coleman A, Katz J, Sommer A (1995) The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med 332:1205–1209 doi:10.1056/NEJM199505043321806
Schotliff K, Duncan G (2005) Diabetes: chronic complications. In: Shaw KM, Cummings MH (Eds) Wiley, New York
Chia E, Mitchell P, Rochtchina E, Foran S, Wang J (2003) Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 87:392–395 doi:10.1136/bjo.87.4.392
Unruh M, Yan G, Radeva M, Hays R, Benz R, Athienites N, Kusek J, Levey A, Meyer K (2003) Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study. J Am Soc Nephrol 14:2132–2141 doi:10.1097/01.ASN.0000076076.88336.B1
Acknowledgements
The authors would like to thank two anonymous reviewers for their valuable comments on the paper. This research was supported by Lilly Germany GmbH, Bad Homburg.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davidov, E., Breitscheidel, L., Clouth, J. et al. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol 247, 267–272 (2009). https://doi.org/10.1007/s00417-008-0960-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0960-y